Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperacti-vation of complement,angiopathic thrombosis,and protein-losing enteropathy disease:An open-label phase 2 and 3 study
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperacti-vation of complement,angiopathic thrombosis,and protein-losing enteropathy disease:An open-label phase 2 and 3 study
国家科技期刊平台
NSTL
万方数据